11:31 AM EDT, 08/07/2025 (MT Newswires) -- Genmab ( GMAB ) shares rose more than 5% in recent Thursday trading after the company reported Q2 net profit of $5.42 per diluted share, up from $3.13 a year earlier.

Revenue for the quarter ended June 30 was $925 million, up from $779 million a year earlier.

Analysts polled by FactSet expected $904.3 million.

For 2025, the company said it now expects revenue of $3.5 billion to $3.7 billion, compared with its prior outlook of $3.34 billion to $3.66 billion. Analysts surveyed by FactSet expect $3.56 billion.

Price: 22.70, Change: +1.19, Percent Change: +5.51